| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pbs application for mepolizumab | 0.34 | 0.3 | 4475 | 5 | 31 |
| pbs | 1.26 | 0.4 | 5391 | 92 | 3 |
| application | 0.34 | 0.7 | 9613 | 19 | 11 |
| for | 1.76 | 1 | 1252 | 91 | 3 |
| mepolizumab | 0.98 | 0.5 | 2496 | 89 | 11 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pbs application for mepolizumab | 0.19 | 0.4 | 8793 | 46 |
| pbs omalizumab initial application | 0.69 | 0.9 | 5588 | 85 |
| mepolizumab package insert pdf | 0.91 | 0.5 | 9422 | 17 |
| what is mepolizumab used for | 1.39 | 0.3 | 101 | 35 |
| mepolizumab package insert fda | 1.19 | 0.5 | 5436 | 82 |
| mepolizumab reslizumab and benralizumab | 0.91 | 0.5 | 1376 | 12 |
| what is mepolizumab used to treat | 1.39 | 0.3 | 400 | 69 |
| mepolizumab mechanism of action | 0.1 | 0.5 | 3758 | 91 |
| mepolizumab administration cpt code | 0.68 | 0.9 | 1729 | 16 |
| is mepolizumab an immunosuppressant | 0.42 | 0.3 | 2173 | 5 |
| injection mepolizumab 1 mg | 0.19 | 1 | 200 | 93 |
| mepolizumab side effects forum | 1.89 | 0.3 | 1637 | 37 |
| mepolizumab product monograph canada | 0.8 | 0.1 | 8697 | 94 |
| does mepolizumab cause immunosuppression | 0.26 | 0.5 | 7651 | 70 |
